UroCor LabsSM bladder prognostics assist in helping to predict the recurrence and progression of bladder cancer by using UroCor’s proprietary p53 Prognostic Assay run off a simple urine specimen.
Can you see which of these bladder cancer patients is more likely to
progress?
Transitional cell carcinoma
Stage T1N0 M0 Grade II
Transitional cell carcinoma
Stage T1N0 M0 Grade II
Click here to see how you can predict cancer recurrence and progression with UroCor LabsSM p53 proprietary analysis.
